Health products• Updated Jan 3• APO-Metformin
APO-Metformin recall in Canada: May contain NDMA above acceptable limits
This recall involves APO-Metformin 500 mg Extended Release Tablets sold in Canada. It's being recalled because affected
APO-Metformin Recalls in Canada
All product recalls associated with APO-Metformin in Canada, sourced from Health Canada, Transport Canada, and the CFIA.
2 recalls
Most recent: Jun 12, 2020